Galenika a.d., once great manufacturer of pharmaceutical raw materials and the only manufacturer of penicillin and insulin in the Balkans, in time adapted its activities to global trends in this area.
High level of specialization, growth of capacities and opening of global pharmaceutical raw materials market led to differentiation and clearer division to raw materials manufacturers and pharmaceutical preparations manufacturers. Galenika a.d. left on its track of developing pharmaceutical preparations production. It kept the unique traits and development results from its rich tradition – biosynthesis of organically bound oligoelements. Manufacturing of these substances is being performed in Raw Materials Plant.
Quality of Raw Materials Plant products is determined according to current criteria of global standards (USP, BP, NF, FiP etc). Quality is frequently controlled according to in-house specifications, which are a combination of global criteria with additional requirements of the specific market.
The largest part of this base production is intended for in-house use, i.e. further processing in plants of Galenika a.d. One part of the production is intended for the domestic market, i.e. various industries in it: chemical, civil engineering, leather processing, textile, rubber and plastics industries, and occasionally for export. The plant has UNIDO certificate for clean production, which shows the level of care for sustainable environment, an has great potential for future development.